# Selective Axillary Lymph Node Dissection Vs Complete Axillary Dissection: A Randomised Clinical Trial to Assess the Prevention of Lymphedema in Breast Cancer Treatment

> **NCT03083314** · NA · COMPLETED · sponsor: **Fondazione IRCCS Istituto Nazionale dei Tumori, Milano** · enrollment: 130 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **PROCEDURE:** SELECTIVE AXILLARY LYMPH NODE DISSECTION (SAD)
- **PROCEDURE:** COMPLETE AXILLARY DISSECTION (ALND)

## Key facts

- **NCT ID:** NCT03083314
- **Lead sponsor:** Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06-12
- **Primary completion:** 2018-11-15
- **Final completion:** 2020-12-04
- **Target enrollment:** 130 (ACTUAL)
- **Last updated:** 2021-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03083314

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03083314, "Selective Axillary Lymph Node Dissection Vs Complete Axillary Dissection: A Randomised Clinical Trial to Assess the Prevention of Lymphedema in Breast Cancer Treatment". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03083314. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*